American Academy of Pediatrics
This presentation is the property of its rightful owner.
Sponsored Links
1 / 5

P-SATT Leadership Team PowerPoint PPT Presentation

  • Uploaded on
  • Presentation posted in: General

American Academy of Pediatrics Provisional Section on Advances in Therapeutics and Technology (P-SATT). P-SATT Leadership Team. Charlie Thompson (Chair), MD FAAP Chair, Executive Committee General Pediatrics Medical Director, Pfizer Inc Brahm Goldstein, MD MCR FAAP

Download Presentation

P-SATT Leadership Team

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript

P satt leadership team

American Academy of PediatricsProvisional Section on Advances in Therapeutics and Technology(P-SATT)

P satt leadership team

P-SATT Leadership Team

  • Charlie Thompson (Chair), MD FAAP

    • Chair, Executive Committee

    • General Pediatrics

    • Medical Director, Pfizer Inc

  • Brahm Goldstein, MD MCR FAAP

    • Member, Executive Committee

    • Chair, Membership & Communication Subcommittee

    • Pediatric Critical Care

    • Senior Medical Director, Ikaria Inc

  • Gwen Levy, MD FAAP

    • Member, Executive Committee

    • Program Chair, National Conference & Exhibition

    • General Pediatrics

    • Global Safety Medical Director

    • Amgen

  • Sam Maldonado, MD FAAP

    • Chair, Liaison Subcommittee

    • Pediatric Infectious Diseases

    • Vice President & Head of Pediatric Drug Development Center of Excellence, Janssen Pharmacuetical Companies

  • Andrew Mulberg, MD FAAP

    • Member, Executive Committee

    • Pediatric Gastroenterology

    • Division Deputy Director, Gastroenterology and Inborn Errors Products

    • Food and Drug Administration

  • Ron Portman, MD FAAP FASN

    • Member, Executive Committee

    • Chair, Government Subcommittee

    • Pediatric Nephrology

    • Group Director, Bristol-Myers Squibb

  • Chuck Schubert, MD MPH FAAP

    • Chair, Safety Subcommittee

    • General Pediatrics

    • Senior Medical Director, Patient Safety

    • AstraZeneca

  • Stephen Spielberg, MD PhD FAAP

    • Member, Executive Committee

    • Chair, Education Subcommittee

    • Pharmacology

    • Director, Center for Personalized Medicine and Therapeutic Innovation , Children's Mercy Hospital

  • Seth Toback, MD FAAP

    • Newsletter Editor & ListServ Moderator

    • General Pediatrics

    • Medical Director, MedImmune

  • Paul Wang, MD FAAP

    • Member, Executive Committee

    • Chair, Research Subcommittee

    • Behavioral and Developmental Pediatrics

    • Vice President, Seaside Therapeutics

P satt goals and objectives

P-SATT Goals and Objectives

  • Mission

    • To advance pediatric health and well-being through collaboration, communication and education on the discovery and development of therapeutics and technology and their successful translation into practice

  • Goals

    • Communication

      • To improve communication and relationships with AAP members within industry, academia and government agencies to create opportunity for dialogue with the organizations that employ them

    • Education

      • To educate AAP membership on the discovery, development, and implementation process for therapeutics and technology

    • Networking

      • To create a vibrant member community and network that will add value to AAP members

      • To serve as a resource and integrate expertise with other Sections, Committees and membership-at-large

    • Integration

      • To explore the research and development process and make recommendations that will improve quality, safety, understanding and efficiency

P satt proposed 2011 activities

P-SATT Proposed 2011 Activities

  • Communication

    • Develop a dialogue with AAP Leadership on potential areas of collaboration between the AAP, industry, academia, and government agencies (e.g., FDA)

  • Education

    • Educate AAP members about drug discovery and development, clinical research and regulatory issues involving new therapeutics and technology for children

      • Section education program at 2011 AAP on advancing pediatric medicine

    • Educate AAP members about alternative career paths (e.g., industry, government)

  • Networking

    • Develop strategies to recruit AAP members from diverse background into the Section, connect them to each other, and engage them in a meaningful way in the work of the section

    • Develop liaisons with other AAP sections and committees

  • Integration

    • Explore ways to improve the process of drug/device research and development and its translation to everyday practice

    • Explore relationships between AAP, industry, academia and government agencies (e.g., FDA)

How to join p satt

How To Join P-SATT

  • If you are a member of the AAP, please follow the instructions below to join our section

    • 1) Follow the link to the AAP Member Center


    • 2) Log in as an AAP member

    • 3) Check the box for “Advances in Therapeutics and Technology” and complete the remainder of the form.

  • If you are not yet an AAP member but are eligible to join, please follow the link below to join the AAP and then follow the section instructions above


  • Login